두개내 동맥류 시장 규모, 점유율, 동향 분석 : 유형별(클리핑술, 혈관내 코일색전술, 혈류우회장치), 최종사용자별(병원, 클리닉), 지역별, 부문별 예측(2022-2030년)

Intracranial Aneurysm Market Growth & Trends:

The global intracranial aneurysm market size is anticipated to reach USD 2.3 billion by 2030, according to a new report by Grand View Research, Inc. The market is anticipated to witness a CAGR of 9.0% from 2022 to 2030. The increasing incidence rate of brain aneurysms worldwide and the growing number of patients suffering from hypertension are expected to drive the market in the coming years. The COVID-19 outbreak in the year 2020 have a negative impact on the market as the majority of elective neuro procedures were suspended to free-up limited space in healthcare settings to treat COVID-19 patients.

However, patients suffering from COVID-19 have subsequently shown neurologic symptoms that are expected to create a favorable environment for market growth in the near future. Currently, the cause of brain aneurysms is not clearly understood. However, several factors associated with this disease include brain injury, aging, atherosclerosis infection, hereditary, sedentary lifestyle, and hypertension. Few prominent symptoms include cranial nerve palsy, localized headache, and double vision. Thus, the increasing number of patients suffering from an intracranial aneurysm is significantly fueling the market growth.

Furthermore, the introduction of new systems for treating intracranial aneurysms is also expected to propel market growth. In October 2019, Per-flow Medical received CE mark approval for its Cascade Agile. This cascade agile enhances control for tortuous and distal vessel anatomy at the time of coil embolization. Similarly, in April 2019, Stryker launched a flow diverter (Surpass Evolve Flow Diverter) for the treatment of brain aneurysms. Therefore, complications related to treatment have been reduced with the help of these technological advancements.

Intracranial Aneurysm Market Report Highlights:

• Based on type, the endovascular coiling segment dominated the market and accounted for a revenue share of 85.1% in 2021 due to increasing application in minimally invasive neurosurgeries and its easy access to multiple aneurysms in the distant area

• Based on end-use, the hospitals' segment dominated the market in 2021 with a share of 89.5%. Since intracranial aneurysm procedures are amongst the most complicated surgeries that are dependent on high-quality and durable equipment available in hospitals

• North America dominated the market with the highest revenue share of 27.2% in 2021 owing to the growing aging population and high incidence of hypertension and stroke in the region

Table of Content

Chapter 1 Methodology and Scope

• 1.1 Market Segmentation and Scope
  • 1.1.1 Type
  • 1.1.2 End-Use
  • 1.1.3 Regional Scope
  • 1.1.4 Estimates And Forecast Timeline
• 1.2 Research Methodology
• 1.3 Information procurement
  • 1.3.1 Purchased Database:
  • 1.3.2 Gvr's Internal Database
  • 1.3.3 Secondary Sources
  • 1.3.4 Primary Research
  • 1.3.5 Details Of Primary Research
• 1.4 Information Or Data Analysis
  • 1.4.1 Data Analysis Models
• 1.5 Market Formulation & Validation
• 1.6 Model Details
  • 1.6.1 Commodity Flow Analysis (Model 1)
    • 1.6.1.1 Approach 1: Commodity Flow Approach
  • 1.6.2 Volume Price Analysis (Model 2)
    • 1.6.2.1 Approach 2: Volume price analysis
• 1.7 List of Secondary Sources
• 1.8 List of Primary Sources
• 1.9 List of Abbreviations
• 1.10 Objectives
  • 1.10.1 Objective 1
  • 1.10.2 Objective 2
  • 1.10.3 Objective 3
  • 1.10.4 Objective 4

Chapter 2 Executive Summary

• 2.1 Market Outlook
• 2.2 Segment Outlook
• 2.3 Competitive Insights

Chapter 3 Intracranial Aneurysm Market Variables, Trends & Scope

• 3.1 Market Lineage Outlook
  • 3.1.1 Parent Market Outlook
  • 3.1.2 Ancillary Market Outlook
• 3.2 Penetration & Growth Prospect Mapping
• 3.3 List of Key End-users
• 3.4 Market Dynamics
  • 3.4.1 Market Driver Analysis
    • 3.4.1.1 Rising prevalence of brain aneurysm
    • 3.4.1.2 Introduction of technologically advanced products
    • 3.4.1.3 Rise in demand for minimally invasive procedures
    • 3.4.1.4 Rise in research and development activities
  • 3.4.2 Market Restraints Analysis
    • 3.4.2.1 High cost of treatment
• 3.5 Intracranial Aneurysm: Market Analysis Tools
  • 3.5.1 Industry Analysis - Porter's
  • 3.5.2 Pestle Analysis
  • 3.5.3 Major Deals And Strategic Alliances
    • 3.5.3.1 New Product Launch
    • 3.5.3.2 Acquisition
    • 3.5.3.3 Partnerships
  • 3.5.4 Market Entry Strategies

Chapter 4 Intracranial Aneurysm Market: Segment Analysis, By Type, 2018 - 2030 (USD Million)

• 4.1 Definition and Scope
• 4.2 Type Market Share Analysis, 2021 & 2030
• 4.3 Segment Dashboard
• 4.4 Global Intracranial Aneurysm Market, By Type, 2018 to 2030
• 4.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
  • 4.5.1 Surgical Clipping
    • 4.5.1.1 Surgical Clipping Market, 2018 To 2030 (USD Million)
  • 4.5.2 Endovascular Coiling
    • 4.5.2.1 Endovascular Coiling Market, 2018 To 2030 (USD Million)
  • 4.5.3 Flow Diverters
    • 4.5.3.1 Flow Diverters Market, 2018 TO 2030 (USD Million)
  • 4.5.4 Others
    • 4.5.4.1 Others Market, 2018 TO 2030 (USD Million)

Chapter 5 Intracranial Aneurysm Market: Segment Analysis, By End-use, 2018 - 2030 (USD Million)

• 5.1 Definition and Scope
• 5.2 End-use Market Share Analysis, 2021 & 2030
• 5.3 Segment Dashboard
• 5.4 Global Intracranial Aneurysm Market, By End-use, 2018 to 2030
• 5.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
  • 5.5.1 Hospitals
    • 5.5.1.1 Hospitals Market, 2018 - 2030 (USD Million)
  • 5.5.2 Clinics
    • 5.5.2.1 Clinics Market, 2018 - 2030 (USD Million)
  • 5.5.3 Others
    • 5.5.3.1 Others Market, 2018 - 2030 (USD Million)

Chapter 6 Intracranial Aneurysm Market: Regional Market Analysis, By Type, End-use, 2018 - 2030 (USD Million)

• 6.1 Definition & Scope
• 6.2 Regional Market Share Analysis, 2021 & 2030
• 6.3 Regional Market Dashboard
• 6.4 Regional Market Snapshot
• 6.5 Market Size, & Forecasts, and Trend Analysis, 2021 & 2030
• 6.6 North America
  • 6.6.1 North America Market Estimates And Forecast, By Country, 2018-2030 (USD Million)
  • 6.6.2 North America Intracranial Aneurysm Market, By Type, 2018 - 2030 (USD Million)
  • 6.6.3 North America Intracranial Aneurysm Market, By End-Use, 2018 - 2030 (USD Million)
  • 6.6.4 U.S.
    • 6.6.4.1 U.S. Intracranial Aneurysm Market, 2018 - 2030 (USD Million)
  • 6.6.5 Canada
    • 6.6.5.1 Canada Intracranial Aneurysm Market, 2018 - 2030 (USD Million)
• 6.7 Europe
  • 6.7.1 Europe Intracranial Aneurysm Market, By Country, 2018 - 2030 (USD Million)
  • 6.7.2 Europe Intracranial Aneurysm Market, By Type, 2018 - 2030 (USD Million)
  • 6.7.3 Europe Intracranial Aneurysm Market, By End-Use, 2018 - 2030 (USD Million)
  • 6.7.4 U.K.
    • 6.7.4.1 U.K. Intracranial Aneurysm Market, 2018 - 2030 (USD Million)
  • 6.7.5 Germany
    • 6.7.5.1 Germany Intracranial Aneurysm Market, 2018 - 2030 (USD Million)
  • 6.7.6 France
    • 6.7.6.1 France Intracranial Aneurysm Market, 2018 - 2030 (USD Million)
  • 6.7.7 Italy
    • 6.7.7.1 Italy Intracranial Aneurysm Market, 2018 - 2030 (USD Million)
  • 6.7.8 Spain
    • 6.7.8.1 Spain Intracranial Aneurysm Market, 2018 - 2030 (USD Million)
• 6.8 Asia Pacific
  • 6.8.1 Asia Pacific Intracranial Aneurysm Market, By Country, 2018 - 2030 (USD Million)
  • 6.8.2 Asia Pacific Intracranial Aneurysm Market, By Type, 2018 - 2030 (USD Million)
  • 6.8.3 Asia Pacific Intracranial Aneurysm Market, By End-Use, 2018 - 2030 (USD Million)
  • 6.8.4 Japan
    • 6.8.4.1 Japan Intracranial Aneurysm Market, 2018 - 2030 (USD Million)
  • 6.8.5 China
    • 6.8.5.1 China Intracranial Aneurysm Market, 2018 - 2030 (USD Million)
  • 6.8.6 India
    • 6.8.6.1 India Intracranial Aneurysm Market, 2018 - 2030 (USD Million)
  • 6.8.7 South Korea
    • 6.8.7.1 South Korea Intracranial Aneurysm Market, 2018 - 2030 (USD Million)
  • 6.8.8 Australia
    • 6.8.8.1 Australia Intracranial Aneurysm Market, 2018 - 2030 (USD Million)
• 6.9 Latin America
  • 6.9.1 Latin America Intracranial Aneurysm Market, By Country, 2018 - 2030 (USD Million)
  • 6.9.2 Latin America Intracranial Aneurysm Market, By Type, 2018 - 2030 (USD Million)
  • 6.9.3 Latin America Intracranial Aneurysm Market, By End-Use, 2018 - 2030 (USD Million)
  • 6.9.4 Brazil
    • 6.9.4.1 Brazil Intracranial Aneurysm Market, 2018 - 2030 (USD Million)
  • 6.9.5 Mexico
    • 6.9.5.1 Mexico Intracranial Aneurysm Market, 2018 - 2030 (USD Million)
  • 6.9.6 Argentina
    • 6.9.6.1 Argentina Intracranial Aneurysm Market, 2018 - 2030 (USD Million)
  • 6.9.7 Colombia
    • 6.9.7.1 Colombia Intracranial Aneurysm Market, 2018 - 2030 (USD Million)
• 6.10 MEA
  • 6.10.1 MEA Intracranial Aneurysm Market, By Country, 2018 - 2030 (USD Million)
  • 6.10.2 MEA Intracranial Aneurysm Market, By Type, 2018 - 2030 (USD Million)
  • 6.10.3 MEA Intracranial Aneurysm Market, By End-Use, 2018 - 2030 (USD Million)
  • 6.10.4 South Africa
    • 6.10.4.1 South Africa Intracranial Aneurysm Market, 2018 - 2030 (USD Million)
  • 6.10.5 Saudi Arabia
    • 6.10.5.1 Saudi Arabia Intracranial Aneurysm Market, 2018 - 2030 (USD Million)
  • 6.10.6 UAE
    • 6.10.6.1 UAE Intracranial Aneurysm Market, 2018 - 2030 (USD Million)

Chapter 7 Intracranial Aneurysm Market - Competitive Analysis

• 7.1 Recent Developments & Impact Analysis, by Key Market Participants
  • 7.1.1 Ansoff Matrix
• 7.2 Private Companies
  • 7.2.1 Regional Network Map
  • 7.2.2 Company Market Position Analysis
• 7.3 Company Profiles
  • 7.3.1 MEDTRONIC
    • 7.3.1.1 Company overview
    • 7.3.1.2 Financial performance
    • 7.3.1.3 Product benchmarking
    • 7.3.1.4 Strategic initiatives
  • 7.3.2 MICROPORT SCIENTIFIC CORPORATION
    • 7.3.2.1 Company overview
    • 7.3.2.2 Financial performance
    • 7.3.2.3 Product benchmarking
    • 7.3.2.4 Strategic initiatives
  • 7.3.3 B. BRAUN MELSUNGEN AG
    • 7.3.3.1 Company overview
    • 7.3.3.2 Financial performance
    • 7.3.3.3 Product benchmarking
  • 7.3.4 STRYKER
    • 7.3.4.1 Company overview
    • 7.3.4.2 Financial performance
    • 7.3.4.3 Product benchmarking
    • 7.3.4.4 Strategic initiatives
  • 7.3.5 JOHNSON AND JOHNSON SERVICES, INC.
    • 7.3.5.1 Company overview
    • 7.3.5.2 Financial performance
    • 7.3.5.3 Product benchmarking
    • 7.3.5.4 Strategic initiatives
  • 7.3.6 MICROVENTION INC. (TERUMO CORPORATION)
    • 7.3.6.1 Company overview
    • 7.3.6.2 Financial performance
    • 7.3.6.3 Product benchmarking
    • 7.3.6.4 Strategic initiatives
  • 7.3.7 CODMAN NEURO (INTEGRA LIFESCIENCES CORPORATION)
    • 7.3.7.1 Company overview
    • 7.3.7.2 Financial performance
    • 7.3.7.3 Product benchmarking
    • 7.3.7.4 Strategic initiatives